ArticleNagoya journal of medical science2025
High-dose-rate surface mold with tumor translucency brachytherapy for a 103-year-old patient with skin cancer, dementia, tremor, and kyphosis: a case report.
Article in Nagoya journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer treatment for centenarians can be challenging. High-dose-rate surface mold brachytherapy is a non-invasive, radical treatment modality for surface cancer. Further, it is used for patients who cannot remain at rest or have poor posture. We performed this treatment on a 103-year-old female patient with forehead skin cancer, dementia, tremors, and kyphosis since radical surgery and external beam radiotherapy were not feasible. A custom-made surface mold with tube applicators was developed with vinyl sheet and silicone. The vinyl sheet was utilized to enable tumor visualization through the mold and to confirm the tumor position relative to the mold. The mold with tumor translucency was fixed to the tumor surface, and the radioisotope (Ir-193) was sent remotely through tube applicators for irradiation. The planning-aim doses were 48 Gy in eight fractions. The positional relationship between the mold and the tumor was confirmed similarly during irradiation by checking them through the vinyl sheet before and after irradiation. We treated the patient, although she was in constant motion during irradiation. The local tumor was well-controlled without any metastatic disease evidence. The tumor disappeared before her eventual death 11 months post-treatment. No serious adverse events were reported during the follow-up period. Our results indicate that high-dose-rate surface mold with tumor translucency brachytherapy is an effective cancer treatment for centenarians with dementia, tremors, and kyphosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.